SENORES PHARMACEUTICALS L Share Price

₹ 1,144.90

+₹25.30 (2.26%)
1D
Last updated 03 Nov, 2026, 10:03 IST
NSE: SENORES
|
Pharmaceuticals

SENORES PHARMACEUTICALS L Share Price Today

As of 3 Nov 2026, SENORES PHARMACEUTICALS L share price is ₹1,144.90. The stock opened at ₹1,115.20, compared to its previous close of ₹1,119.60. During today's trading session, SENORES PHARMACEUTICALS L share price moved in the range of ₹1,096.40 to ₹1,156.00, with an average price of ₹1,126.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹706.00 and a high of ₹1,599.00. On the performance front, SENORES PHARMACEUTICALS L share price has increased by 24.51% over the last six months and is up 45.18% on a year-on-year basis.

Share price over the last 1 day rose from 1115.30 to 1145.20, ranging between 1097.70 and 1154.10.
₹1,096.40
2.26% up today
₹1,156.00
1D LOW
1D HIGH

SENORES PHARMACEUTICALS L Stock Insights

Latest Earning
Op Profit TrendUp by 20.58% QoQ
Latest Earning
Net Profit TrendUp by 20.20% QoQ
Latest Earning
Revenue TrendUp by 9.97% QoQ
Stock Performance
OutperformingBeat Nifty by 31.22 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 8.57%
Shareholding Pattern
FIIFII decreased stake by 9.21%
SENORES PHARMACEUTICALS L stock performance
Open₹1,115.20
High₹1,156.00
Low₹1,096.40
Prev. close₹1,119.60
SENORES PHARMACEUTICALS L trading activity
Volume1,23,535
Average traded price₹1,128.32
Last traded time10:03:31 03 Nov
Last traded quantity3
Circuit
L
H
₹895.70
₹1,343.50
52-week
L
H
₹706.00
₹1,599.00
Mkt Cap Cr
5,220.63
P/E
38.03
P/B
5.21
ROA
8.17%
ROE
13.31%
ROCE
14.7%
EV/EBITDA
22.5

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Senores Pharma. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Senores Pharma. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Senores Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%22.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%58.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%33.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%54.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%16.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%19.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%21.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%25.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%12.38
Lupin91,870.1616.454.0714.47%23.76%24.88%9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SENORES PHARMACEUTICALS L Company Background

ISIN
INE0RB801010
Sector Market Cap
₹ 5,220.63 Cr

Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychloroquine Sulfate Tablets USP, 200 mg; Ketoconazole Tablets USP, 200 mg; Chlorzoxazone Tablets USP, 250 mg; 5Chlorzoxazone Tablets USP, 500 mg; Ketorolac Tromethamine Tablets USP, 10 mg; Diclofenac Potassium Tablets USP, 25 mg; Diclofenac Potassium Tablets USP, 50 mg, and others. It supplies affordable APIs to generic formulations manufacturers. Its product API include Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Azithromycin for Injection; Meropenem Injection; Ferric Carboxymaltose Injection; Meropenem and Sulbactam for Injection, and others.

SENORES PHARMACEUTICALS L Financial Highlights

  • Revenue: SENORES PHARMACEUTICALS L reported revenue of ₹679.69 crore in FY26 vs ₹417.51 crore in FY25. It showed an increase of 62.80% on a yearly basis.
  • Operating Profit: SENORES PHARMACEUTICALS L reported an operating profit of ₹159.10 crore in FY26 vs ₹70.57 crore in FY25. It showed an increase of 125.45% on a year-on-year basis.
  • Net Profit: SENORES PHARMACEUTICALS L reported a net profit of ₹121.52 crore in FY26 vs ₹58.34 crore in FY25. It showed an increase of 108.30% on a yearly basis.

SENORES PHARMACEUTICALS L Quarterly Result Highlights

  • SENORES PHARMACEUTICALS L reported revenue of ₹201.27 crore in Sep 2026, compared with ₹183.02 crore in Jun 2026, representing an increase of 9.97% on a quarter-on-quarter (QoQ) basis.
  • SENORES PHARMACEUTICALS L reported an operating profit of ₹47.58 crore in Sep 2026, compared with ₹39.46 crore in Jun 2026, representing an increase of 20.58% on a quarter-on-quarter (QoQ) basis.
  • SENORES PHARMACEUTICALS L reported a profit of ₹36.60 crore in Sep 2026, compared with ₹30.45 crore in Jun 2026, reflecting an increase of 20.20% on a QoQ basis.
  • The earnings per share (EPS) of SENORES PHARMACEUTICALS L stood at ₹16.12 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
45.82%
FII
6.01%
Other DII
3.49%
Retail and other
37.33%
Mutual funds
7.36%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20253.35%
Mar 20263.64%
Jun 20266.62%
Sep 20266.01%

SENORES PHARMACEUTICALS L Investment Returns

1 day
-1.26%
1 week
-10.11%
1 month
-17.04%
1 year
+45.18%
3 years
+100.99%
5 years
+100.99%

SENORES PHARMACEUTICALS L Share Price History

SENORES PHARMACEUTICALS L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,145.60 / ₹1,119.60
-1.26%
30 Oct 26
₹1,219.20 / ₹1,133.90
-7.00%
29 Oct 26
₹1,324.30 / ₹1,219.20
-7.94%
28 Oct 26
₹1,315.00 / ₹1,324.30
+1.01%
Show more

SENORES PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹398.25₹214.52₹35.34₹14.17
Other Income₹19.26₹2.82₹3.68₹0.46
Total Revenue₹417.51₹217.34₹39.02₹14.63
Total Expenses₹346.94₹192.40₹26.58₹13.49
Profit Before Tax₹70.57₹24.94₹12.44₹1.14
Tax₹12.23-₹7.77₹4.00₹0.15
Profit After Tax₹58.34₹32.71₹8.43₹0.99
EPS - Basic₹16.12₹13.67₹8.87₹1.81
EPS - Diluted₹16.12₹12.21₹6.65₹1.81

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹159.10₹70.57₹24.94₹12.44
Income before WC changes₹217.09₹97.68₹42.83₹14.98
Change in Assets-₹308.32-₹94.67-₹118.75-₹27.67
Change in Liabilities₹166.48-₹39.76₹52.70₹13.06
Change in WC-₹141.84-₹134.43-₹66.05-₹14.61
Cash flow from Operations₹62.05-₹45.92-₹25.70-₹1.08
Cash flow from Investing-₹120.56-₹429.48-₹54.23-₹48.29
Cash flow from Financing-₹1.33₹573.13₹86.98₹46.25
Total Cash Flow-₹59.84₹97.73₹7.05-₹3.12
Cash (Start of the year)₹105.38₹7.65₹0.10₹3.22
Cash (End of the year)₹45.55₹105.38₹7.65₹0.10

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹504.43₹370.97₹79.72₹32.10
Current Assets₹722.43₹250.91₹51.34₹27.05
Total Assets₹1,226.86₹621.88₹131.05₹59.15
Current Liabilities₹240.70₹247.50₹51.88₹9.89
Net Current Asset₹481.73₹3.41-₹0.55₹17.17
Non-Current Liabilities₹173.92₹142.67₹33.67₹12.68
Equity Capital₹812.24₹231.71₹45.50₹36.59
Total Equity & Liabilities₹1,226.86₹621.88₹131.05₹59.15

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹38.54₹34.01₹12.38₹13.54
Other Income₹21.99₹6.84₹6.79₹0.94
Total Revenue₹60.53₹40.85₹19.17₹14.48
Total Expenses₹55.42₹38.82₹17.23₹13.65
Profit Before Tax₹5.11₹2.03₹1.94₹0.83
Tax₹1.42₹1.22₹0.74₹0.15
Profit After Tax₹3.69₹0.81₹1.20₹0.68
EPS - Basic₹1.02₹0.35₹1.26₹1.24
EPS - Diluted₹1.02₹0.32₹0.95₹1.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹27.46₹5.11₹2.03₹1.94
Income before WC changes₹10.24-₹4.79-₹0.56₹3.52
Change in Assets-₹57.91-₹20.49-₹24.01-₹16.22
Change in Liabilities₹25.57₹6.33₹6.50-₹27.09
Change in WC-₹32.34-₹14.16-₹17.51-₹43.32
Cash flow from Operations-₹26.88-₹20.40-₹19.26-₹43.41
Cash flow from Investing-₹19.46-₹436.25-₹57.07-₹5.23
Cash flow from Financing-₹2.64₹532.62₹86.68₹47.08
Total Cash Flow-₹48.98₹75.97₹10.35-₹1.57
Cash (Start of the year)₹81.20₹5.23₹0.09₹1.66
Cash (End of the year)₹32.22₹81.20₹10.44₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹422.02₹245.90₹84.04₹41.19
Current Assets₹412.07₹39.96₹27.68₹13.98
Total Assets₹834.09₹285.86₹111.72₹55.17
Current Liabilities₹41.23₹90.64₹46.79₹8.80
Net Current Asset₹370.84-₹50.68-₹19.11₹5.18
Non-Current Liabilities₹84.89₹27.10₹26.01₹12.68
Equity Capital₹707.97₹168.12₹38.92₹33.69
Total Equity & Liabilities₹834.09₹285.86₹111.72₹55.17
* All values are in INR Crore
SENORES PHARMACEUTICALS L market depth
Bid quantityBid priceAsk priceAsk quantity
41144.61144.92
31144.511453
41144.41145.29
141144.31145.333
101144.21145.45
Total bid quantity35
Total ask quantity52
SENORES PHARMACEUTICALS L technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
31.8
Neutral
ATR (14)
71.06
Neutral
STOCH(9,6)
20.03
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
29.11
Bearish
UO(9)
45.46
Neutral
ROC(12)
-13.3
Bearish
WillR(14)
-80.25
Bullish
Period
Simple value
Exponential vaue
5D
1246.78
1219.21
10D
1244.79
1244.63
20D
1286.13
1280.26
50D
1379.34
1330.29
100D
1368.39
1297.68
Volume trend — traded volume by day
3 Nov1L
2 Nov5L
30 Oct23L
29 Oct10L
28 Oct1L
27 Oct2L
Average7L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SENORES PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

SENORES PHARMACEUTICALS L Returns Calculator

SENORES PHARMACEUTICALS L Latest News

3 months ago
Mainboard IPOs in December 2024: A mixed trend for newly listed stocks, a look at top 5 performers
Showing news item 1 of 1

Top Gainers

TRIDENT Share Price
₹24.49
+2.28 (+10.27%)
KRBL Share Price
₹398.15
+35.15 (+9.68%)
GRSE Share Price
₹2201.90
+155.1 (+7.58%)
MARICO Share Price
₹854.90
+56.35 (+7.06%)
MOTILALOFS Share Price
₹1023.50
+59.1 (+6.13%)
See more

Top Losers

KEC Share Price
₹322.65
-26.35 (-7.55%)
GNFC Share Price
₹478.60
-32.4 (-6.34%)
PRAJIND Share Price
₹259.69
-11.44 (-4.22%)
GESHIP Share Price
₹1549.90
-50.5 (-3.16%)
BIOCON Share Price
₹345.00
-9.7 (-2.73%)
See more

SENORES PHARMACEUTICALS L Share Price FAQs

Please be aware that SENORES PHARMACEUTICALS L stock prices are subject to continuous fluctuations due to various factors.